Publication:
Response to "High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma".

dc.contributor.authorVega, Francisco M
dc.contributor.authorColmenero-Repiso, Ana
dc.contributor.authorGómez-Muñoz, María A
dc.contributor.authorRodríguez-Prieto, Ismael
dc.contributor.authorAguilar-Morante, Diana
dc.contributor.authorRamírez, Gema
dc.contributor.authorMárquez, Catalina
dc.contributor.authorCabello, Rosa
dc.contributor.authorPardal, Ricardo
dc.date.accessioned2023-02-08T14:43:21Z
dc.date.available2023-02-08T14:43:21Z
dc.date.issued2020-03-13
dc.identifier.doi10.1016/j.ebiom.2020.102703
dc.identifier.essn2352-3964
dc.identifier.pmcPMC7078286
dc.identifier.pmid32179496
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078286/pdf
dc.identifier.unpaywallURLhttp://www.thelancet.com/article/S2352396420300785/pdf
dc.identifier.urihttp://hdl.handle.net/10668/15245
dc.journal.titleEBioMedicine
dc.journal.titleabbreviationEBioMedicine
dc.language.isoen
dc.organizationInstituto de Biomedicina de Sevilla-IBIS
dc.organizationHospital Universitario Virgen del Rocío
dc.organizationHospital Universitario Virgen del Rocío
dc.page.number102703
dc.pubmedtypeJournal Article
dc.pubmedtypeComment
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectCD44 expression
dc.subjectNeuroblastoma
dc.subjectSurvival
dc.subjectUndifferentiation
dc.subject.meshHumans
dc.subject.meshHyaluronan Receptors
dc.subject.meshNeuroblastoma
dc.subject.meshPrognosis
dc.titleResponse to "High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma".
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number53
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC7078286.pdf
Size:
433.75 KB
Format:
Adobe Portable Document Format